Annual report

Period2022-12-01 → 2023-11-30
Filed2024-02-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥8.6bn2022-12-01 → 2023-11-30Cons.Net sales
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales
Revenue¥7.9bn2020-12-01 → 2021-11-30dCons.Net sales (5-year summary)
Revenue¥6.6bn2019-12-01 → 2020-11-30dCons.Net sales (5-year summary)
Revenue¥7.5bn2018-12-01 → 2019-11-30dCons.Net sales (5-year summary)
Operating income¥354m2022-12-01 → 2023-11-30Cons.Operating income
Operating income¥294m2021-12-01 → 2022-11-30Cons.Operating income
Ordinary income¥345m2022-12-01 → 2023-11-30Cons.Ordinary income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥386m2020-12-01 → 2021-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥83m2019-12-01 → 2020-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥187m2018-12-01 → 2019-11-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥342m2022-12-01 → 2023-11-30Cons.Income before income taxes
Profit before tax¥283m2021-12-01 → 2022-11-30Cons.Income before income taxes
Net income (owners)¥256m2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥281m2020-12-01 → 2021-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥59m2019-12-01 → 2020-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥147m2018-12-01 → 2019-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥256m2022-12-01 → 2023-11-30Cons.Profit loss
Net income¥219m2021-12-01 → 2022-11-30Cons.Profit loss
Total assets¥8.3bnat 2023-11-30Cons.Assets
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.9bnat 2021-11-30dCons.Total assets (5-year summary)
Total assets¥7.2bnat 2020-11-30dCons.Total assets (5-year summary)
Total assets¥7.3bnat 2019-11-30dCons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2023-11-30Cons.Liabilities
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Net assets / equity¥2.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.3bnat 2021-11-30dCons.Net assets
Net assets / equity¥2.0bnat 2020-11-30dCons.Net assets (5-year summary)
Net assets / equity¥1.9bnat 2019-11-30dCons.Net assets (5-year summary)
Cash and deposits¥1.0bnat 2023-11-30Cons.Cash and deposits
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
Cash & equivalents¥1.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30dCons.Cash and cash equivalents
Cash & equivalents¥883mat 2020-11-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥397mat 2019-11-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥470m2022-12-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥21m2021-12-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥785m2020-12-01 → 2021-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥654m2019-12-01 → 2020-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥286m2018-12-01 → 2019-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥370m2022-12-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥243m2021-12-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥246m2020-12-01 → 2021-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥392m2019-12-01 → 2020-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥907m2018-12-01 → 2019-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥21m2022-12-01 → 2023-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥162m2021-12-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥119m2020-12-01 → 2021-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥222m2019-12-01 → 2020-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥349m2018-12-01 → 2019-11-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥209.882022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥230.992020-12-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.732019-12-01 → 2020-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥120.482018-12-01 → 2019-11-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥2,167.14at 2023-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,980.62at 2022-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,850.07at 2021-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,619.73at 2020-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,600.24at 2019-11-30dCons.Net assets per share (5-year summary)
Equity ratio31.6%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2021-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio27.4%at 2020-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio26.7%at 2019-11-30dCons.Equity to asset ratio (5-year summary)
ROE10.1%2022-12-01 → 2023-11-30Cons.Rate of return on equity (5-year summary)
ROE9.4%2021-12-01 → 2022-11-30Cons.Rate of return on equity (5-year summary)
ROE13.3%2020-12-01 → 2021-11-30dCons.Rate of return on equity (5-year summary)
ROE3.0%2019-12-01 → 2020-11-30dCons.Rate of return on equity (5-year summary)
ROE7.7%2018-12-01 → 2019-11-30dCons.Rate of return on equity (5-year summary)
Employees166at 2023-11-30Cons.Number of employees
Employees171at 2022-11-30Cons.Number of employees
Employees165at 2021-11-30dCons.Number of employees
Employees173at 2020-11-30dCons.Number of employees
Employees164at 2019-11-30dCons.Number of employees
Revenue¥8.4bn2022-12-01 → 2023-11-30StandaloneNet sales
Revenue¥8.2bn2021-12-01 → 2022-11-30StandaloneNet sales
Revenue¥7.7bn2020-12-01 → 2021-11-30dStandaloneNet sales (5-year summary)
Revenue¥6.5bn2019-12-01 → 2020-11-30dStandaloneNet sales (5-year summary)
Revenue¥7.4bn2018-12-01 → 2019-11-30dStandaloneNet sales (5-year summary)
Operating income¥341m2022-12-01 → 2023-11-30StandaloneOperating income
Operating income¥249m2021-12-01 → 2022-11-30StandaloneOperating income
Ordinary income¥333m2022-12-01 → 2023-11-30StandaloneOrdinary income
Ordinary income¥262m2021-12-01 → 2022-11-30StandaloneOrdinary income
Ordinary income¥329m2020-12-01 → 2021-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥59m2019-12-01 → 2020-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥162m2018-12-01 → 2019-11-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥330m2022-12-01 → 2023-11-30StandaloneIncome before income taxes
Profit before tax¥243m2021-12-01 → 2022-11-30StandaloneIncome before income taxes
Net income¥246m2022-12-01 → 2023-11-30StandaloneProfit loss
Net income¥185m2021-12-01 → 2022-11-30StandaloneProfit loss
Net income¥242m2020-12-01 → 2021-11-30dStandaloneNet income loss (5-year summary)
Net income¥40m2019-12-01 → 2020-11-30dStandaloneNet income loss (5-year summary)
Net income¥128m2018-12-01 → 2019-11-30dStandaloneNet income loss (5-year summary)
Total assets¥8.1bnat 2023-11-30StandaloneAssets
Total assets¥8.2bnat 2022-11-30StandaloneAssets
Total assets¥7.8bnat 2021-11-30dStandaloneTotal assets (5-year summary)
Total assets¥7.1bnat 2020-11-30dStandaloneTotal assets (5-year summary)
Total assets¥7.2bnat 2019-11-30dStandaloneTotal assets (5-year summary)
Total liabilities¥5.7bnat 2023-11-30StandaloneLiabilities
Total liabilities¥5.9bnat 2022-11-30StandaloneLiabilities
Net assets / equity¥2.5bnat 2023-11-30StandaloneNet assets
Net assets / equity¥2.2bnat 2022-11-30StandaloneNet assets
Net assets / equity¥2.1bnat 2021-11-30dStandaloneNet assets
Net assets / equity¥1.9bnat 2020-11-30dStandaloneNet assets (5-year summary)
Net assets / equity¥1.9bnat 2019-11-30dStandaloneNet assets (5-year summary)
Cash and deposits¥834mat 2023-11-30StandaloneCash and deposits
Cash and deposits¥683mat 2022-11-30StandaloneCash and deposits
EPS (basic)¥201.872022-12-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥151.852021-12-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥198.642020-12-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥32.472019-12-01 → 2020-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥104.92018-12-01 → 2019-11-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥502022-12-01 → 2023-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-12-01 → 2022-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-12-01 → 2021-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥302019-12-01 → 2020-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥302018-12-01 → 2019-11-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,015.67at 2023-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,847.66at 2022-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,758.24at 2021-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,573.45at 2020-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,571.92at 2019-11-30dStandaloneNet assets per share (5-year summary)
Equity ratio30.2%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio27.6%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio27.6%at 2021-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio26.9%at 2020-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio26.4%at 2019-11-30dStandaloneEquity to asset ratio (5-year summary)
ROE10.5%2022-12-01 → 2023-11-30StandaloneRate of return on equity (5-year summary)
ROE8.4%2021-12-01 → 2022-11-30StandaloneRate of return on equity (5-year summary)
ROE11.9%2020-12-01 → 2021-11-30dStandaloneRate of return on equity (5-year summary)
ROE2.1%2019-12-01 → 2020-11-30dStandaloneRate of return on equity (5-year summary)
ROE6.8%2018-12-01 → 2019-11-30dStandaloneRate of return on equity (5-year summary)
Shares issued1,220,000at 2023-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2022-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2021-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2020-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2019-11-30dStandaloneTotal number of issued shares (5-year summary)
Employees160at 2023-11-30StandaloneNumber of employees
Employees166at 2022-11-30StandaloneNumber of employees
Employees159at 2021-11-30dStandaloneNumber of employees
Employees167at 2020-11-30dStandaloneNumber of employees
Employees159at 2019-11-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentcapex2022-12-01 → 2023-11-30¥314m
Pharmaceutical Productsreportable segmentdepreciation2022-12-01 → 2023-11-30¥406m
Pharmaceutical Productsreportable segmentemployeesat 2023-11-30165 pure
Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-11-30¥8.6bn
Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-11-30¥8.6bn
Pharmaceutical Productsreportable segmentsegment assetsat 2023-11-30¥8.3bn
Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-11-30¥323m
Real Estate Leasingreportable segmentemployeesat 2023-11-301 pure
Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-11-30¥38m
Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-11-30¥38m
Real Estate Leasingreportable segmentsegment assetsat 2023-11-30¥71m
Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-11-30¥31m
Total Of Reportable Segments And Otherssegment totalcapex2022-12-01 → 2023-11-30¥314m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-12-01 → 2023-11-30¥406m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-11-30¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-11-30¥8.6bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-11-30¥8.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-11-30¥354m
Pharmaceutical Productsreportable segmentcapex2021-12-01 → 2022-11-30¥382m
Pharmaceutical Productsreportable segmentdepreciation2021-12-01 → 2022-11-30¥396m
Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentsegment assetsat 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-11-30¥263m
Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-11-30¥38m
Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-11-30¥38m
Real Estate Leasingreportable segmentsegment assetsat 2022-11-30¥71m
Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-11-30¥30m
Total Of Reportable Segments And Otherssegment totalcapex2021-12-01 → 2022-11-30¥382m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-12-01 → 2022-11-30¥396m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-11-30¥8.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-11-30¥8.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-11-30¥8.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-11-30¥294m
Pharmaceutical Productsreportable segmentemployeesat 2023-11-30159 pure
Real Estate Leasingreportable segmentemployeesat 2023-11-301 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,441
ItemContextValueUnit
Reserve for advanced depreciation of noncurrent assetsPrior1YearInstant_NonConsolidatedMember9755000JPY
Reserve for advanced depreciation of noncurrent assetsCurrentYearInstant_NonConsolidatedMember8549000JPY
General reservePrior1YearInstant_NonConsolidatedMember600000000JPY
General reserveCurrentYearInstant_NonConsolidatedMember600000000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember822313000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember1008413000JPY
Other retained earningsPrior1YearInstant_NonConsolidatedMember1432069000JPY
Other retained earningsCurrentYearInstant_NonConsolidatedMember1616962000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember1561999000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember1746892000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-8202000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-8202000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2222234000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember2407128000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember27233000JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember46890000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember27233000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember46890000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2249468000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember2454019000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember8152708000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember8130062000JPY
Net sales of finished goods rev oaPrior1YearDuration_NonConsolidatedMember8149111000JPY
Net sales of finished goods rev oaCurrentYearDuration_NonConsolidatedMember8385072000JPY
Rent income of real estate rev oaPrior1YearDuration_NonConsolidatedMember38033000JPY
Rent income of real estate rev oaCurrentYearDuration_NonConsolidatedMember38274000JPY
Net salesPrior1YearDuration_NonConsolidatedMember8187144000JPY
Net salesCurrentYearDuration_NonConsolidatedMember8423347000JPY
Beginning finished goods cosPrior1YearDuration_NonConsolidatedMember820569000JPY
Beginning finished goods cosCurrentYearDuration_NonConsolidatedMember1054061000JPY
Cost of products manufacturedPrior1YearDuration_NonConsolidatedMember7023174000JPY
Cost of products manufacturedCurrentYearDuration_NonConsolidatedMember7000731000JPY
Total beginning finished goods and cost of products manufactured for the periodPrior1YearDuration_NonConsolidatedMember7843744000JPY
Total beginning finished goods and cost of products manufactured for the periodCurrentYearDuration_NonConsolidatedMember8054793000JPY
Finished goods transfer to other account cosPrior1YearDuration_NonConsolidatedMember-20571000JPY
Finished goods transfer to other account cosCurrentYearDuration_NonConsolidatedMember-11972000JPY
Ending finished goods cosPrior1YearDuration_NonConsolidatedMember1054061000JPY
Ending finished goods cosCurrentYearDuration_NonConsolidatedMember1059462000JPY
Cost of real estate rent cos exp oaPrior1YearDuration_NonConsolidatedMember7608000JPY
Cost of real estate rent cos exp oaCurrentYearDuration_NonConsolidatedMember7608000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember6817861000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember7014912000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember1369282000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember1408435000JPY
Selling expenses sgaPrior1YearDuration_NonConsolidatedMember178464000JPY
Selling expenses sgaCurrentYearDuration_NonConsolidatedMember174751000JPY
General and administrative expenses sgaPrior1YearDuration_NonConsolidatedMember941548000JPY
General and administrative expenses sgaCurrentYearDuration_NonConsolidatedMember892598000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1120013000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1067349000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-11-30pass
balance sheet identitynon_consolidated 2022-11-30pass rounding
balance sheet identitynon_consolidated 2023-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsnon_consolidated 2021-11-30pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-11-30pass
statement vs summary · revenueconsolidated 2021-12-01/2022-11-30pass
statement vs summary · revenueconsolidated 2022-12-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2021-12-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2022-12-01/2023-11-30pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsnon_consolidated 2022-11-30pass
statement vs summary · total assetsnon_consolidated 2023-11-30pass